ACS Medicinal Chemistry Letters
Novel Compounds as Glucagon-Like Peptide-1 Receptor Agonists for Treating Type 2 Diabetes Mellitus and Obesity
By Ram W. Sabnis.
Abstract
Abstract Provided herein are novel compounds as GLP-1R agonists, pharmaceutical compositions, use of such compounds in treating type 2 diabetes mellitus and obesity, and processes for preparing such compounds.
Keywords
- Diabetes Treatment and Management
- GLP-1 receptor agonists
- type 2 diabetes
- obesity
- new compounds
- drug formulation
- compound preparation
- Open access
Source
Published in ACS Medicinal Chemistry Letters. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
